Skip to main content
Log in

Bone microarchitecture in Rett syndrome and treatment with teriparatide: a case report

  • Case Report
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

We present the case of a 28-year-old female Rett syndrome patient with low bone mass and a recent fracture who was successfully treated with teriparatide. Bone mineral density and microarchitecture substantially improved after treatment. Rett syndrome (RTT), an X-linked progressive neuro-developmental disorder caused by mutations in the methyl-CpG-binding 2 (MECP2) gene, has been consistently associated with low bone mass. Consequently, patients with RTT are at increased risk of skeletal fractures. Teriparatide is a bone-forming agent for the treatment of osteoporosis that has demonstrated its effectiveness in increasing bone strength and reducing the risk of fractures in postmenopausal women, but, recently, its positive action has also been reported in premenopausal women. We present the case of a 28-year-old female RTT patient with low bone mass and a recent fracture who was successfully treated with teriparatide. Both bone mass measured by DXA and microarchitecture assessed by high resolution peripheral computed tomography (HR pQCT) were substantially improved after treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Abbreviations

RTT:

Rett syndrome

MECP2:

methyl-CpG-binding 2

HR-pQCT:

high resolution peripheral computarized tomography

References

  1. Lyst MJ, Bird A (2015) Rett syndrome: a complex disorder with simple roots. Nat Rev Genet 16:261–275

    Article  CAS  PubMed  Google Scholar 

  2. Laurvick CL, de Klerk N, Bower C, Christodoulou J, Ravine D, Ellaway C, Williamson S, Leonard H (2006) Rett syndrome in Australia: a review of the epidemiology. J Pediatr 148:347–352

    Article  PubMed  Google Scholar 

  3. Weaving LS, Ellaway CJ, Gécz J, Christodoulou J (2005) Rett syndrome: clinical review and genetic update. J Med Genet 42:1–7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Haas RH, Dixon SD, Sartoris DJ, Hennessy MJ (1997) Osteopenia in Rett syndrome. J Pediatr 131:771–774

    Article  CAS  PubMed  Google Scholar 

  5. Downs J, Bebbington A, Woodhead H, Jacoby P, Jian L, Jefferson A, Leonard H (2008) Early determinants of fractures in Rett syndrome. Pediatrics 121:540–546

    Article  PubMed  Google Scholar 

  6. Jefferson AL, Woodhead HJ, Fyfe S, Briody J, Bebbington A, Strauss BJ, Jacoby P, Leonard H (2011) Bone mineral content and density in Rett syndrome and their contributing factors. Pediatr Res 69:293–298

    Article  PubMed  PubMed Central  Google Scholar 

  7. Motil KJ, Ellis KJ, Barrish JO, Caeg E, Glaze DG (2008) Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome. Pediatr Res 64:435–439

    Article  PubMed  PubMed Central  Google Scholar 

  8. Budden SS, Gunness ME (2001) Bone histomorphometry in three females with Rett syndrome. Brain Dev 23:S133–S137

    Article  PubMed  Google Scholar 

  9. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733

    Article  CAS  PubMed  Google Scholar 

  10. Blue ME, Boskey AL, Doty SB, Fedarko NS, Hossain MA, Shapiro JR (2015) Osteoblast function and bone histomorphometry in a murine model of Rett syndrome. Bone 76:23–30

    Article  PubMed  Google Scholar 

  11. Kamal B, Russell D, Payne A, Constante D, Tanner KE, Isaksson H, Mathavan N, Cobb SR (2015) Biomechanical properties of bone in a mouse model of Rett syndrome. Bone 71:106–114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Jefferson A, Leonard H, Siafarikas A, Woodhead H, Fyfe S, Ward LM et al (2016) Clinical guidelines for management of bone health in Rett syndrome based on expert consensus and available evidence. PLoS ONE 11:e0146824

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lotan M, Reves-Siesel R, Eliav-Shalev RS, Merrick J (2013) Osteoporosis in Rett syndrome: a case study presenting a novel management intervention for severe osteoporosis. Osteoporos Int 24:3059–3063

    Article  CAS  PubMed  Google Scholar 

  14. Caffarelli C. Teriparatide in the treatment of recurrent fractures in a Rett patient. Clin Cases Min Bone Metab. 2015.

  15. Girotra M, Rubin MR, Bilezikian JP (2006) The use of parathyroid hormone in the treatment of osteoporosis. Rev Endocr Metab Disord 7:113–121

    Article  CAS  PubMed  Google Scholar 

  16. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. Obstet Gynecol Surv 56:623–624

    Article  Google Scholar 

  17. Cohen A, Stein EM, Recker RR, Lappe JM, Dempster DW, Zhou H, Cremers S, McMahon DJ, Nickolas TL, Müller R, Zwahlen A, Young P, Stubby J, Shane E (2013) Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab 98:1971–1981

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the child and her family for allowing us to use the medical documentation and information that led to the present article.

We thank Susana Carballo for editing the English language of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. B. Zanchetta.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zanchetta, M.B., Scioscia, M.F. & Zanchetta, J.R. Bone microarchitecture in Rett syndrome and treatment with teriparatide: a case report. Osteoporos Int 27, 2873–2877 (2016). https://doi.org/10.1007/s00198-016-3586-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-016-3586-7

Keywords

Navigation